Archives of Clinical Infectious Diseases

Published by: Kowsar

Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study

Behnam Farhoudi 1 , Amin Alipour 1 , Saeed Ghodrati 2 , Seyedahmad Seyedalinaghi 3 , * , Mehrangiz Zanganeh 1 and Minoo Mohraz 3
Authors Information
1 Clinical Research Development Center, Amir-Almomenin Hospital, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, IR Iran
2 Shahid Beheshti University, Tehran, IR Iran
3 Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2018, 13 (2); e57911
  • Published Online: April 25, 2018
  • Article Type: Research Article
  • Received: January 2, 2017
  • Revised: July 10, 2017
  • Accepted: September 19, 2017
  • DOI: 10.5812/archcid.57911

To Cite: Farhoudi B, Alipour A, Ghodrati S, Seyedalinaghi S, Zanganeh M, et al. Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study, Arch Clin Infect Dis. 2018 ; 13(2):e57911. doi: 10.5812/archcid.57911.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
5. Conclusions
Acknowledgements
Footnote
References
  • 1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. doi: 10.1056/NEJMra050100. [PubMed: 16079372].
  • 2. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35(3):261-8. [PubMed: 15076240].
  • 3. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357-66. [PubMed: 10770537].
  • 4. Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051-8. [PubMed: 11953472].
  • 5. Carballo E, Cadarso-Suarez C, Carrera I, Fraga J, de la Fuente J, Ocampo A, et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res. 2004;13(3):587-99. doi: 10.1023/B:QURE.0000021315.93360.8b. [PubMed: 15130023].
  • 6. Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10-22. [PubMed: 15832830].
  • 7. Lima VD, Geller J, Bangsberg DR, Patterson TL, Daniel M, Kerr T, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175-83. doi: 10.1097/QAD.0b013e32811ebf57. [PubMed: 17502728].
  • 8. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27(3):251-9. [PubMed: 11464144].
  • 9. Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9(5):713-9. [PubMed: 15535408].
  • 10. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18 Suppl 1:S19-25. [PubMed: 15075494]. [PubMed Central: PMC2886736].
  • 11. Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11(2):185-94. doi: 10.1007/s10461-006-9152-0. [PubMed: 16897351]. [PubMed Central: PMC2867605].
  • 12. Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care. 2004;16(2):199-211. doi: 10.1080/09540120410001641048. [PubMed: 14676026].
  • 13. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386-95. [PubMed: 10866231].
  • 14. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40-9. doi: 10.1037/0278-6133.26.1.40. [PubMed: 17209696]. [PubMed Central: PMC2863998].
  • 15. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12(4):387-98. doi: 10.1080/09540120050123783. [PubMed: 11091771].
  • 16. Palmer NB, Salcedo J, Miller AL, Winiarski M, Arno P. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care STDS. 2003;17(12):635-44. doi: 10.1089/108729103771928690. [PubMed: 14746657].
  • 17. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124-33. [PubMed: 10762096].
  • 18. Mellins CA, Kang E, Leu CS, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care STDS. 2003;17(8):407-16. doi: 10.1089/108729103322277420. [PubMed: 13678542].
  • 19. Vranceanu AM, Safren SA, Lu M, Coady WM, Skolnik PR, Rogers WH, et al. The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. AIDS Patient Care STDS. 2008;22(4):313-21. doi: 10.1089/apc.2007.0069. [PubMed: 18338960].
  • 20. Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248-57. [PubMed: 12709091]. [PubMed Central: PMC1494846].
  • 21. Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488-95. doi: 10.1037/0278-6133.26.4.488. [PubMed: 17605569]. [PubMed Central: PMC4044097].
  • 22. Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28-33. doi: 10.1080/09540120600652303. [PubMed: 17129855].
  • 23. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035-41. [PubMed: 15545859].
  • 24. Beals KP, Wight RG, Aneshensel CS, Murphy DA, Miller-Martinez D. The role of family caregivers in HIV medication adherence. AIDS Care. 2006;18(6):589-96. doi: 10.1080/09540120500275627. [PubMed: 16831787].
  • 25. Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH. Adherence to antiretroviral therapy among Iranian HIV/AIDS patients. Curr Clin Pharmacol. 2012;7(2):111-5. [PubMed: 22432842].
  • 26. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944-50. [PubMed: 12499488]. [PubMed Central: PMC2871670].
  • 27. Soto Blanco JM, Perez IR, March JC. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain). Int J STD AIDS. 2005;16(2):133-8. doi: 10.1258/0956462053057503. [PubMed: 15807941].
  • 28. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28(5):445-9. [PubMed: 11744832].
  • 29. Emamzadeh-Fard S, Fard SE, SeyedAlinaghi S, Paydary K. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review. Infect Disord Drug Targets. 2012;12(5):346-56. [PubMed: 23017163].
  • 30. SeyedAlinaghi SA, Paydary K, Afsar Kazerooni P, Hosseini M, Sedaghat A, Emamzadeh-Fard S, et al. Evaluation of Stigma Index Among People Living With HIV/AIDS (PLWHA) in Six Cities in Iran. Thrita J Med Sci. 2013;2(2):69-75. doi: 10.5812/thrita.11801.
  • 31. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006;20(5):359-68. doi: 10.1089/apc.2006.20.359. [PubMed: 16706710].
  • 32. Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA J. 2009;6(4):148-54. [PubMed: 20485854].
  • 33. Barfod TS, Hecht FM, Rubow C, Gerstoft J. Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory. BMC Health Serv Res. 2006;6:154. doi: 10.1186/1472-6963-6-154. [PubMed: 17144910]. [PubMed Central: PMC1702356].
  • 34. Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav. 2006;10(3):253-61. doi: 10.1007/s10461-006-9069-7. [PubMed: 16482405].
  • 35. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14(1):88-90. [PubMed: 7737079].
  • 36. Delahanty DL, Bogart LM, Figler JL. Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care. 2004;16(2):247-60. doi: 10.1080/09540120410001641084. [PubMed: 14676029].
  • 37. Paydary K, Ekhtiari H, Noori M, Rad MV, Hajiabdolbaghi M, SeyedAlinaghi S. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients. Infect Disord Drug Targets. 2015;15(3):177-83. [PubMed: 26411558].
  • 38. Goujard C, Bernard N, Sohier N, Peyramond D, Lancon F, Chwalow J, et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;34(2):191-4. [PubMed: 14526208].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments